Excerpt from Clinical Transplants 2011
The Historical Development and Current Status of the China Marrow Donor Program
Junling Hong China Marrow Donor Program, Beijing, China Corresponding
The incidence of leukemia in China is above 3 per 100,000 population, which means that 50,000 new leukemia patients are diagnosed each year in China. Facing an enormous demand for hematopoietic stem cell (HSC) transplantation, the Chinese government entrusted the Red Cross Society of China with the establishment of the China Marrow Donor Program (CMDP) in 2001. Like the National Marrow Donor Program (NMDP) in America, the CMDP's operation covers donor recruiting, HLA typing, donor searching, IT infrastructure, and clinical transplant, as well as providing stem cells to other countries. Presently, the CMDP has established 31 provincial level branches, 30 HLA contract labs, and 35 contract transplant centers. To date, 2,539 patients in China have been transplanted with stem cells from the CMDP. The overall one -year survival is about 70 %. This summary will present the CMDP's development, current situation, and future prospects.